PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
FSIAX vs. FSMEX
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Performance

FSIAX vs. FSMEX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Fidelity Advisor Strategic Income Fund Class M (FSIAX) and Fidelity Select Medical Technology and Devices Portfolio (FSMEX). The values are adjusted to include any dividend payments, if applicable.

-4.00%-2.00%0.00%2.00%4.00%6.00%8.00%JuneJulyAugustSeptemberOctoberNovember
4.65%
5.69%
FSIAX
FSMEX

Returns By Period

In the year-to-date period, FSIAX achieves a 6.30% return, which is significantly lower than FSMEX's 8.52% return. Over the past 10 years, FSIAX has underperformed FSMEX with an annualized return of 2.84%, while FSMEX has yielded a comparatively higher 6.19% annualized return.


FSIAX

YTD

6.30%

1M

-0.02%

6M

4.37%

1Y

11.09%

5Y (annualized)

2.14%

10Y (annualized)

2.84%

FSMEX

YTD

8.52%

1M

-1.35%

6M

3.93%

1Y

19.96%

5Y (annualized)

2.87%

10Y (annualized)

6.19%

Key characteristics


FSIAXFSMEX
Sharpe Ratio2.781.36
Sortino Ratio4.381.95
Omega Ratio1.571.24
Calmar Ratio1.180.56
Martin Ratio16.234.95
Ulcer Index0.66%4.26%
Daily Std Dev3.87%15.42%
Max Drawdown-17.80%-43.45%
Current Drawdown-0.97%-24.74%

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


FSIAX vs. FSMEX - Expense Ratio Comparison

FSIAX has a 0.96% expense ratio, which is higher than FSMEX's 0.68% expense ratio.


FSIAX
Fidelity Advisor Strategic Income Fund Class M
Expense ratio chart for FSIAX: current value at 0.96% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.96%
Expense ratio chart for FSMEX: current value at 0.68% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.68%

Correlation

-0.50.00.51.00.2

The correlation between FSIAX and FSMEX is 0.22, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Risk-Adjusted Performance

FSIAX vs. FSMEX - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Fidelity Advisor Strategic Income Fund Class M (FSIAX) and Fidelity Select Medical Technology and Devices Portfolio (FSMEX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for FSIAX, currently valued at 2.78, compared to the broader market-1.000.001.002.003.004.005.002.781.23
The chart of Sortino ratio for FSIAX, currently valued at 4.38, compared to the broader market0.005.0010.004.381.78
The chart of Omega ratio for FSIAX, currently valued at 1.57, compared to the broader market1.002.003.004.001.571.22
The chart of Calmar ratio for FSIAX, currently valued at 1.18, compared to the broader market0.005.0010.0015.0020.0025.001.180.51
The chart of Martin ratio for FSIAX, currently valued at 16.23, compared to the broader market0.0020.0040.0060.0080.00100.0016.234.40
FSIAX
FSMEX

The current FSIAX Sharpe Ratio is 2.78, which is higher than the FSMEX Sharpe Ratio of 1.36. The chart below compares the historical Sharpe Ratios of FSIAX and FSMEX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Rolling 12-month Sharpe Ratio0.001.002.003.004.00JuneJulyAugustSeptemberOctoberNovember
2.78
1.23
FSIAX
FSMEX

Dividends

FSIAX vs. FSMEX - Dividend Comparison

FSIAX's dividend yield for the trailing twelve months is around 4.06%, while FSMEX has not paid dividends to shareholders.


TTM20232022202120202019201820172016201520142013
FSIAX
Fidelity Advisor Strategic Income Fund Class M
4.06%4.05%3.37%2.44%3.06%3.18%3.39%2.88%3.23%3.46%5.08%4.94%
FSMEX
Fidelity Select Medical Technology and Devices Portfolio
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.18%0.00%11.71%5.17%9.84%

Drawdowns

FSIAX vs. FSMEX - Drawdown Comparison

The maximum FSIAX drawdown since its inception was -17.80%, smaller than the maximum FSMEX drawdown of -43.45%. Use the drawdown chart below to compare losses from any high point for FSIAX and FSMEX. For additional features, visit the drawdowns tool.


-35.00%-30.00%-25.00%-20.00%-15.00%-10.00%-5.00%0.00%JuneJulyAugustSeptemberOctoberNovember
-0.97%
-24.74%
FSIAX
FSMEX

Volatility

FSIAX vs. FSMEX - Volatility Comparison

The current volatility for Fidelity Advisor Strategic Income Fund Class M (FSIAX) is 0.83%, while Fidelity Select Medical Technology and Devices Portfolio (FSMEX) has a volatility of 3.88%. This indicates that FSIAX experiences smaller price fluctuations and is considered to be less risky than FSMEX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


1.00%2.00%3.00%4.00%5.00%6.00%7.00%JuneJulyAugustSeptemberOctoberNovember
0.83%
3.88%
FSIAX
FSMEX